Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Case report

Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment

Authors: Norbert Harrasser, Ingo J Banke, Matthias Hauschild, Ulrich Lenze, Peter M Prodinger, Andreas Toepfer, Christian Peschel, Rüdiger von Eisenhart-Rothe, Ingo Ringshausen, Mareike Verbeek

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Mucormycosis is an invasive mycotic disease caused by fungi in the zygomycetes class. Although ubiquitous in the environment, zygomycetes are rarely known to cause invasive disease in immunocompromised hosts with a high mortality even under aggressive antifungal and surgical therapy. Clinically, mucormycosis frequently affects the sinus occasionally showing pulmonary or cerebral involvement. However skeletal manifestation with Rhizopus microsporus (RM) osteomyelitis leading to emergency surgical proximal femoral resection with fatal outcome has not been described yet.

Case presentation

We report the case of a 73-year-old male suffering from myelodysplastic syndrome with precedent bone marrow transplantation. Six months after transplantation he consulted our internal medicine department in a septic condition with a four week history of painful swelling of the right hip. Radiography, computed tomography and magnetic resonance imaging revealed multiple bone infarcts in both femurs. In the right femoral head, neck and trochanteric region a recent infarct showed massive secondary osteomyelitis, breaking through the medial cortex. Emergency surgical proximal femoral resection was performed due to extensive bone and soft tissue destruction. Microbiological and basic local alignment search tool (BLAST) analysis revealed RM. Amphotericin B and posaconazole treatment with septic revision surgery was performed. However the disease ran a rapid course and was fatal two months after hospital admission.

Conclusion

This alarming result with extensive RM osteomyelitis in the proximal femur of an immunocompromised patient may hopefully warn medical staff to perform early imaging and aggressive surgical supported multimodal treatment in similar cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Krober SM, Horger M, Einsele H, Kanz L, Hebart H: Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica. 2005, 90 Suppl: ECR22-PubMed Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Krober SM, Horger M, Einsele H, Kanz L, Hebart H: Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica. 2005, 90 Suppl: ECR22-PubMed
2.
go back to reference Ye B, Yu D, Zhang X, Shao K, Chen D, Wu D, Zhang Y, Zhou Y, Shen Y, Yu Q: Disseminated Rhizopus microsporus infection following allogeneic hematopoietic stem cell transplantation in a child with severe aplastic anemia. Transpl Infect Dis. 2013, 15 (6): E216-E223. 10.1111/tid.12144.CrossRefPubMed Ye B, Yu D, Zhang X, Shao K, Chen D, Wu D, Zhang Y, Zhou Y, Shen Y, Yu Q: Disseminated Rhizopus microsporus infection following allogeneic hematopoietic stem cell transplantation in a child with severe aplastic anemia. Transpl Infect Dis. 2013, 15 (6): E216-E223. 10.1111/tid.12144.CrossRefPubMed
3.
go back to reference Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O: Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009, 15 (9): 1395-1401. 10.3201/eid1509.090334.CrossRefPubMedPubMedCentral Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O: Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009, 15 (9): 1395-1401. 10.3201/eid1509.090334.CrossRefPubMedPubMedCentral
4.
go back to reference Kontoyiannis DP, Lewis RE: Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006, 20 (3): 581-607. 10.1016/j.idc.2006.06.003. viCrossRefPubMed Kontoyiannis DP, Lewis RE: Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006, 20 (3): 581-607. 10.1016/j.idc.2006.06.003. viCrossRefPubMed
5.
go back to reference Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K: Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009, 48 (3): 265-273. 10.1086/595846.CrossRefPubMed Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K: Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009, 48 (3): 265-273. 10.1086/595846.CrossRefPubMed
6.
7.
go back to reference Hamilos G, Samonis G, Kontoyiannis DP: Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011, 32 (6): 693-702. 10.1055/s-0031-1295717.CrossRefPubMed Hamilos G, Samonis G, Kontoyiannis DP: Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011, 32 (6): 693-702. 10.1055/s-0031-1295717.CrossRefPubMed
8.
go back to reference Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41 (5): 634-653. 10.1086/432579.CrossRefPubMed Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41 (5): 634-653. 10.1086/432579.CrossRefPubMed
9.
go back to reference Vashi N, Avedian R, Brown J, Arai S: Successful surgical and medical treatment of rhizopus osteomyelitis following hematopoietic cell transplantation. Orthopedics. 2012, 35 (10): e1556-e1561. 10.3928/01477447-20120919-30.CrossRefPubMed Vashi N, Avedian R, Brown J, Arai S: Successful surgical and medical treatment of rhizopus osteomyelitis following hematopoietic cell transplantation. Orthopedics. 2012, 35 (10): e1556-e1561. 10.3928/01477447-20120919-30.CrossRefPubMed
10.
go back to reference Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermark J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, et al: Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012, 120 (12): 2454-2465. 10.1182/blood-2012-03-420489.CrossRefPubMedPubMedCentral Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermark J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, et al: Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012, 120 (12): 2454-2465. 10.1182/blood-2012-03-420489.CrossRefPubMedPubMedCentral
11.
go back to reference Cheng VC, Chan JF, Ngan AH, To KK, Leung SY, Tsoi HW, Yam WC, Tai JW, Wong SS, Tse H, Li LW, Lau SK, Woo PC, Leung AY, Lie AK, Liang RH, Que TL, Ho PL, Yuen KY: Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol. 2009, 47 (9): 2834-2843. 10.1128/JCM.00908-09.CrossRefPubMedPubMedCentral Cheng VC, Chan JF, Ngan AH, To KK, Leung SY, Tsoi HW, Yam WC, Tai JW, Wong SS, Tse H, Li LW, Lau SK, Woo PC, Leung AY, Lie AK, Liang RH, Que TL, Ho PL, Yuen KY: Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol. 2009, 47 (9): 2834-2843. 10.1128/JCM.00908-09.CrossRefPubMedPubMedCentral
12.
go back to reference Wilkins RM, Hahn DB, Blum R: Bread mold osteomyelitis in the femur. Orthopedics. 2009, 32 (5): 362-10.3928/01477447-20090501-21.CrossRefPubMed Wilkins RM, Hahn DB, Blum R: Bread mold osteomyelitis in the femur. Orthopedics. 2009, 32 (5): 362-10.3928/01477447-20090501-21.CrossRefPubMed
13.
go back to reference Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y: Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection. Transpl Infect Dis. 2010, 12 (3): 269-272. 10.1111/j.1399-3062.2009.00484.x.CrossRefPubMed Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y: Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection. Transpl Infect Dis. 2010, 12 (3): 269-272. 10.1111/j.1399-3062.2009.00484.x.CrossRefPubMed
14.
go back to reference de Mol P, Meis JF: Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report. Neth J Med. 2009, 67 (1): 25-28.PubMed de Mol P, Meis JF: Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report. Neth J Med. 2009, 67 (1): 25-28.PubMed
15.
go back to reference Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP: Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54 (Suppl 1): S23-S34. 10.1093/cid/cir866.CrossRefPubMed Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP: Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54 (Suppl 1): S23-S34. 10.1093/cid/cir866.CrossRefPubMed
16.
go back to reference Fartoukh M, Prigent H, Thioliere B, Enache-Angoulvant A, Garbarg-Chenon A, Girot R: Fatal fungal superinfection complicating B19 virus-induced massive bone marrow necrosis in sickle-cell disease. Haematologica. 2006, 91 (6 Suppl): ECR18-PubMed Fartoukh M, Prigent H, Thioliere B, Enache-Angoulvant A, Garbarg-Chenon A, Girot R: Fatal fungal superinfection complicating B19 virus-induced massive bone marrow necrosis in sickle-cell disease. Haematologica. 2006, 91 (6 Suppl): ECR18-PubMed
17.
go back to reference Bow EJ: Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician’s viewpoint. Mycopathologia. 2009, 168 (6): 283-297. 10.1007/s11046-009-9196-6.CrossRefPubMed Bow EJ: Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician’s viewpoint. Mycopathologia. 2009, 168 (6): 283-297. 10.1007/s11046-009-9196-6.CrossRefPubMed
18.
go back to reference Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Munoz P, Richardson M, Roilides E, Tartorano AM, et al: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014, 20 (Suppl 3): 5-26.CrossRefPubMed Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Munoz P, Richardson M, Roilides E, Tartorano AM, et al: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014, 20 (Suppl 3): 5-26.CrossRefPubMed
19.
go back to reference Desoubeaux G, Leperlier M, Chaussade H, Schneider C, Roriz M, Houssin C, Rogez C, De Muret A, Garcia-Hermoso D, Bailly E, Le Fourn E, Machet L, Chandenier J, Bernard L: Cutaneous mucormycosis caused by Rhizopus microsporus. Ann Dermatol Venereol. 2014, 141 (3): 201-205. 10.1016/j.annder.2013.10.044.CrossRefPubMed Desoubeaux G, Leperlier M, Chaussade H, Schneider C, Roriz M, Houssin C, Rogez C, De Muret A, Garcia-Hermoso D, Bailly E, Le Fourn E, Machet L, Chandenier J, Bernard L: Cutaneous mucormycosis caused by Rhizopus microsporus. Ann Dermatol Venereol. 2014, 141 (3): 201-205. 10.1016/j.annder.2013.10.044.CrossRefPubMed
20.
go back to reference Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L: Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol. 2006, 44 (3): 267-272. 10.1080/13693780500474327.CrossRefPubMed Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L: Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol. 2006, 44 (3): 267-272. 10.1080/13693780500474327.CrossRefPubMed
21.
go back to reference Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS: Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009, 48 (12): 1743-1751. 10.1086/599105.CrossRefPubMedPubMedCentral Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS: Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009, 48 (12): 1743-1751. 10.1086/599105.CrossRefPubMedPubMedCentral
22.
go back to reference Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N: Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis. 2005, 40 (4): e35-e37. 10.1086/427752.CrossRefPubMed Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N: Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis. 2005, 40 (4): e35-e37. 10.1086/427752.CrossRefPubMed
23.
go back to reference Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA: Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004, 39 (5): 743-746. 10.1086/423274.CrossRefPubMed Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA: Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004, 39 (5): 743-746. 10.1086/423274.CrossRefPubMed
24.
go back to reference van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006, 42 (7): e61-e65. 10.1086/500212.CrossRefPubMed van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006, 42 (7): e61-e65. 10.1086/500212.CrossRefPubMed
25.
go back to reference Ting JY, Chan SY, Lung DC, Ho AC, Chiang AK, Ha SY, Tsoi NN, Chan GC: Intra-abdominal Rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy. J Ped Hematol Oncol. 2010, 32 (6): e238-e240. 10.1097/MPH.0b013e3181e622bf.CrossRef Ting JY, Chan SY, Lung DC, Ho AC, Chiang AK, Ha SY, Tsoi NN, Chan GC: Intra-abdominal Rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy. J Ped Hematol Oncol. 2010, 32 (6): e238-e240. 10.1097/MPH.0b013e3181e622bf.CrossRef
Metadata
Title
Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment
Authors
Norbert Harrasser
Ingo J Banke
Matthias Hauschild
Ulrich Lenze
Peter M Prodinger
Andreas Toepfer
Christian Peschel
Rüdiger von Eisenhart-Rothe
Ingo Ringshausen
Mareike Verbeek
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-488

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.